NEUVIOR is a UK healthtech company building PHARMORIS, a staff-facing medicines action, evidence and governance platform.
PHARMORIS is designed to help healthcare organisations move from medicines signals into governed action: ActionCases, evidence packs, human review, source traceability, blocker tracking, stakeholder acknowledgement, value review and audit trails.
The product is not an autonomous prescribing tool, not a prescribing engine and not a replacement for pharmacists, clinicians, finance, procurement or governance. The current focus is controlled pilot-readiness: credible evidence, clear intended use, source provenance, clinical-safety awareness, information governance, accessibility, standards alignment and decision-grade reporting.
NEUVIOR is especially interested in meeting people working on regulatory science, standards, NHS innovation, AI assurance, clinical safety, medicines optimisation, medtech commercialisation, evidence generation and public-interest innovation.
We are looking for practical conversations with people who can help pressure-test how a health software product moves safely from prototype evidence to controlled pilot use: what evidence matters, what buyers trust, what risks must be controlled, and what makes innovation credible enough to adopt.
Founder, CEO
NEUVIOR® - UK Pharma Infrastructure
Investment
PHARMORIS £1.4m seed round - evidence-led medicines workflow platform
Opening a £1.4m seed round for PHARMORIS: staff-facing medicines workflow software turning signals into governed ActionCases, evidence packs, human review, blocker tracking, value review and audit trails.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Project cooperation
PHARMORIS pilot-readiness cooperation: evidence, standards and NHS adoption
Seeking practical partners to pressure-test PHARMORIS’ route from controlled demo evidence to medicines workflow pilots: intended use, source provenance, standards, AI assurance, DCB0129/DCB0160, DTAC evidence and evaluation.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Product
PHARMORIS - governed medicines action layer
Staff-facing medicines workflow software that turns signals into governed ActionCases, evidence packs, human review, blocker tracking, value review and audit trails. Built for pilot-readiness, source truth and accountable medicines action.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Expertise
Evidence-led healthtech, medicines workflow and pilot-readiness
I can share practical founder/product thinking on healthtech strategy, medicines workflow, evidence generation, source provenance, pilot design, AI governance and buyer-safe positioning for regulated healthcare software.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Request
Seeking input on NHS pilot-readiness evidence
Looking for 15-minute conversations on intended use, source provenance, clinical-safety evidence, DTAC/DCB readiness, standards language, AI governance, procurement and pilot evaluation for medicines workflow software.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Partnership
Strategic partners for medicines workflow pilot-readiness
Open to partnerships with NHS innovation teams, standards/regulatory experts, clinical-safety/IG advisers, medtech operators, funders and delivery partners focused on safer medicines workflow pilots.
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom